PSA Doubling Time Calculator

About the PSA Doubling Time Calculator

PSA doubling time (PSADT) describes how quickly PSA is rising across serial measurements. It is a growth-rate calculation rather than a single-threshold test, which is why it is often used to add context when the question is not simply "is PSA elevated?" but "how fast is the pattern changing over time?"

This calculator derives PSADT from two or three PSA values, calculates PSA velocity, and shows an illustrative projection if the same exponential trend continued. That makes it useful as a kinetics worksheet for recurrence follow-up, surveillance review, or serial PSA discussions. It is still only one layer of context. Assay differences, prostatitis, recent procedures, benign enlargement, absolute PSA level, imaging, pathology, and prior treatment all affect how the number should be interpreted.

When This Page Helps

PSA doubling time is most useful when the main question is how quickly the marker is rising. This page keeps the serial PSA values, elapsed time, velocity, and a simple projected trend in one place so the growth-rate pattern can be reviewed without pretending that one kinetic number decides treatment by itself.

How to Use the Inputs

1. Enter your first (earlier) PSA value in ng/mL
2. Enter your second (later) PSA value — must be higher for doubling time calculation
3. Enter the time interval between measurements in months
4. Optionally enter a third PSA value for validation
5. Review PSADT, velocity, the kinetic range, and the illustrative future PSA values
6. Use the threshold table as a context aid rather than a treatment directive

Example Calculation

Tips & Best Practices

• Use the same PSA assay/laboratory for serial measurements to ensure consistency
• Minimum 3-month interval between PSA values for reliable kinetics
• Three or more PSA values yield more accurate PSADT than just two
• Temporary PSA rises from infection, instrumentation, or post-radiation bounce can distort short-term kinetics
• Absolute PSA level and recurrence definition still matter alongside doubling time
• Use projections as illustrative trend math, not as a forecast of what will definitely happen

Interpreting the Growth Rate

PSA doubling time is a kinetic measure, so it is more informative than a single elevated value when deciding whether the pattern looks indolent or aggressive. A short doubling time usually signals more active disease biology, while a long doubling time suggests slower change.

Use Enough Data

Two values are enough to calculate a number, but more points and longer spacing usually produce a steadier trend. The result is most trustworthy when the same assay is used over time and the lab values are not influenced by transient inflammation or recent procedures.

Combine With the Clinical Context

PSADT is often paired with the biochemical recurrence definition, MRI findings, and treatment history. The calculator is most useful when it supports that broader clinical picture rather than replacing it.

Frequently Asked Questions

• What PSA doubling time is usually treated as worrisome?

  Shorter doubling times, especially under 6 to 12 months, are usually treated as more concerning kinetic patterns than slower rises. The exact implication still depends on context such as recurrence definition, imaging, pathology, absolute PSA level, and treatment history.

• How many PSA values do I need?

  Minimum of two values at different time points. Three or more values improve accuracy. Ideally, measurements should span at least 3–6 months for reliable kinetic calculations.

• What is PSA velocity vs. doubling time?

  PSA velocity is the linear rate of change (ng/mL/year). PSADT measures exponential growth rate. PSADT is generally preferred because tumor growth is exponential, making doubling time more biologically meaningful.

• What defines biochemical recurrence?

  After radical prostatectomy: PSA ≥0.2 ng/mL with a confirmatory rise. After radiation: PSA rise ≥2 ng/mL above the nadir (Phoenix definition). The context affects how PSADT is interpreted clinically.

• Can PSA doubling time be used during active surveillance?

  Yes, but only as one signal. MRI findings, repeat biopsy results, gland size, infection, and the baseline disease features are all part of the surveillance picture, so the kinetics should not be read in isolation.

• Why is my PSA declining — can I still calculate PSADT?

  If PSA is declining, the PSADT equation does not apply (you cannot take the log of a ratio <1). A declining PSA is a favorable sign suggesting treatment response or absence of active disease.